The increased risk of cancer death after a SPC was accentuated in ER-negative vs ER positive breast cancer survivors when compared to FPC except for uterine cancer, which had a greater association in ER-positive survivors (Table 2). This evidence concerns the gene ESR1 and uterine cancer.